Dare Bioscience DARE
NASDAQ DARE
$0.72 +0.00 (+0.50%)
At close: Sep 9, 2026 · 4:00 PM EDT

Dare Bioscience (DARE) Net Shares Issued and Repurchased (2014 - 2018)

Dare Bioscience's (DARE) quarterly Net Shares Issued and Repurchased came in at $3500.0 in Q1 2018, down 99.76% on a YoY basis from $1.5 million in Q1 2017, and down 99.38% quarter-over-quarter from $565372.0 in Q4 2017.

Analysis

Dare Bioscience (DARE) Net Shares Issued and Repurchased (2014 - 2018) Analysis & Trends

Dare Bioscience (DARE) has reported Net Shares Issued and Repurchased for 5 consecutive years, with $3500.0 the latest figure, recorded in Q1 2018.

  • For the quarter ending Q1 2018, Net Shares Issued and Repurchased fell 99.76% year-over-year to $3500.0; the trailing twelve-month figure through Mar 2018 stood at $3500.0 (down 99.76% YoY), and the FY2017 full-year result was $565372.0, down 64.61% from the prior year.
  • Net Shares Issued and Repurchased fell to $3500.0 in Q1 2018 per DARE's latest filing, from $565372.0 in the prior quarter.
  • Across five years, Net Shares Issued and Repurchased topped out at $2.4 million in Q4 2015 and bottomed at $3500.0 in Q1 2018.
  • Historically, Net Shares Issued and Repurchased has averaged $966027.1 across 5 years, with a median of $842820.0 in 2015.
  • The sharpest annual moves came in 2015 and 2018: Net Shares Issued and Repurchased jumped 428.05% in 2015, then tumbled 99.76% in 2018.
  • Over 5 years, Net Shares Issued and Repurchased stood at $1.1 million in 2014, then soared by 107.41% to $2.4 million in 2015, then plunged by 32.33% to $1.6 million in 2016, then tumbled by 64.61% to $565372.0 in 2017, then plunged by 99.38% to $3500.0 in 2018.
  • According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $3500.0, $565372.0, and $1.5 million for Q1 2018, Q4 2017, and Q1 2017 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn -
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn -
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn -
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn -
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn -
10 Dare Bioscience 10.92 Mn -1.70 Mn -132,343.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 3,500.00
Dec 31, 2017 565,372.00
Mar 31, 2017 1.48 Mn
Dec 31, 2016 1.60 Mn
Mar 31, 2016 547,070.00
Dec 31, 2015 2.36 Mn
Mar 31, 2015 842,820.00
Dec 31, 2014 1.14 Mn
Mar 31, 2014 159,610.00